Royal Bank of Canada’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Buy |
|
|||||
|
2025
Q1 | $24K | Sell |
|
|||||
|
2024
Q4 | $37K | Buy |
|
|||||
|
2024
Q3 | $34K | Buy |
|
|||||
|
2024
Q2 | $24K | Buy |
|
|||||
|
2024
Q1 | $13K | Sell |
|
|||||
|
2023
Q4 | $91K | Buy |
|
|||||
|
2023
Q3 | $42K | Buy |
|
|||||
|
2023
Q2 | $30K | Buy |
|
|||||
|
2023
Q1 | $19K | Sell |
|
|||||
|
2022
Q4 | $52K | Buy |
|
|||||
|
2022
Q3 | $26K | Buy |
|
|||||
|
2022
Q2 | $15K | Sell |
|
|||||
|
2022
Q1 | $41K | Sell |
|
|||||
|
2021
Q4 | $100K | Buy |
|
|||||
|
2021
Q3 | $290K | Buy |
|
|||||
|
2021
Q2 | $133K | Buy |
|
|||||
|
2021
Q1 | $60K | Buy |
|
|||||
|
2020
Q4 | $15K | Buy |
|